These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 23242018)
21. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
22. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2. Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128 [TBL] [Abstract][Full Text] [Related]
23. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands. 't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618 [TBL] [Abstract][Full Text] [Related]
24. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. Meng F; Song L; Wang W J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076 [No Abstract] [Full Text] [Related]
25. The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients. Tsou YA; Chang WD; Lu JJ; Wu TF; Chen HL; Chen CM; Tsai MH BMC Cancer; 2019 Aug; 19(1):862. PubMed ID: 31470817 [TBL] [Abstract][Full Text] [Related]
26. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases. Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502 [TBL] [Abstract][Full Text] [Related]
27. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer. Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600 [TBL] [Abstract][Full Text] [Related]
28. Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer. Fransgaard T; Hallas J; Thygesen LC; Gögenur I Surg Oncol; 2019 Mar; 28():62-66. PubMed ID: 30851913 [TBL] [Abstract][Full Text] [Related]
29. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus. Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944 [TBL] [Abstract][Full Text] [Related]
30. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus. Saito A; Kitayama J; Horie H; Koinuma K; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N Cancer Sci; 2020 Nov; 111(11):4012-4020. PubMed ID: 32794612 [TBL] [Abstract][Full Text] [Related]
31. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China. Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197 [TBL] [Abstract][Full Text] [Related]
32. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum. Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481 [TBL] [Abstract][Full Text] [Related]
33. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy. Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362 [TBL] [Abstract][Full Text] [Related]
34. Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy? Ahmed S; Pahwa P; Fields A; Chandra-Kanthan S; Iqbal N; Zaidi A; Reeder B; Plaza FA; Zhu T; Leis A Oncology; 2015; 88(5):289-97. PubMed ID: 25592112 [TBL] [Abstract][Full Text] [Related]
35. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies. Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection. Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278 [TBL] [Abstract][Full Text] [Related]
37. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer? Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848 [TBL] [Abstract][Full Text] [Related]
38. [Metformin can reduce the risk of colorectal cancer]. Fransgård T; Gögenur I Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution. Sudo M; Furuya S; Shimizu H; Nakata Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D World J Surg Oncol; 2019 Mar; 17(1):56. PubMed ID: 30904026 [TBL] [Abstract][Full Text] [Related]
40. Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trials. Christou N; Bergen ES; Canton C; Le Malicot K; Di Bartolomeo M; Galli F; Galli F; Labianca R; Shi Q; Alberts SR; Goldberg RM; Lepage C; Sinicrope FA; Taieb J Eur J Cancer; 2022 May; 166():100-111. PubMed ID: 35279470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]